Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Annals of Surgical Oncology
Published in: Annals of Surgical Oncology 10/2010

01-10-2010 | Melanomas

Prospective Assessment of Postoperative Complications and Associated Costs Following Inguinal Lymph Node Dissection (ILND) in Melanoma Patients

Authors: Sharon B. Chang, MD, Robert L. Askew, MPH, Yan Xing, MD, PhD, Storm Weaver, BA, Jeffrey E. Gershenwald, MD, Jeffrey E. Lee, MD, Richard Royal, MD, Anthony Lucci, MD, Merrick I. Ross, MD, Janice N. Cormier, MD, MPH

Published in: Annals of Surgical Oncology | Issue 10/2010

Login to get access

Abstract

Background

We prospectively assessed the incidence, risk factors, and costs associated with wound complications and lymphedema in melanoma patients undergoing inguinal lymph node dissection (ILND).

Materials and Methods

A total of 53 melanoma patients were accrued to 2 trials (June 2005 to July 2008) that included prospective evaluations of postoperative complications; 30-day wound complications included infection, seroma, and/or dehiscence. There were 20 patients who underwent limb volume measurement and completed a 19-item lymphedema symptom assessment questionnaire preoperatively and 3 months postoperatively. A multivariate analysis was performed to evaluate potential risk factors for complications. A microcosting analysis was also performed to evaluate the direct costs associated with wound complications.

Results

The 30-day wound complications were noted in 77.4% of patients. A BMI ≥ 30 (n = 28) increased the risk for wound complications (odds ratio [OR] = 11.4, 95% confidence interval [95%CI] 1.6–78.5, P = .01), while advanced nodal disease approached significance (OR = 9.0, 95%CI: 0.79–103.1, P = .08). Other risk factors, including diabetes, smoking, and the addition of a deep pelvic (iliac/obturator) dissection to ILND, were not significant. Of 20 patients, 9 (45%) developed limb volume change (LVC) ≥5% at 3 months, with associated mean symptom scores of 6.1 versus 4.6 for those without LVC. Costs for patients with wound complications were significantly higher than for those without wound complications.

Conclusions

Postoperative wound complications and early onset lymphedema occur frequently following ILND for melanoma. Obesity is an adverse risk factor for 30-day wound complications that can significantly increase postoperative costs, as is likely the case for advanced disease. Risk reduction practices and novel treatment approaches are needed to reduce postoperative morbidity.
Literature
1.
Hughes TM, Thomas JM. Combined inguinal and pelvic lymph node dissection for stage III melanoma. Br J Surg. 1999;86:1493–8.CrossRefPubMed
2.
Essner R, Scheri R, Kavanagh M, Torisu-Itakura H, Wanek LA, Morton DL. Surgical management of the groin lymph nodes in melanoma in the era of sentinel lymph node dissection. Arch Surg. 2006;141:877–82; discussion 882–4.CrossRefPubMed
3.
Hughes TM, A’Hern RP, Thomas JM. Prognosis and surgical management of patients with palpable inguinal lymph node metastases from melanoma. Br J Surg. 2000;87:892–901.CrossRefPubMed
4.
Nathansohn N, Schachter J, Gutman H. Patterns of recurrence in patients with melanoma after radical lymph node dissection. Arch Surg. 2005;140:1172–7.CrossRefPubMed
5.
Beitsch P, Balch C. Operative morbidity and risk factor assessment in melanoma patients undergoing inguinal lymph node dissection. Am J Surg. 1992;164:462–5; discussion 465–6.CrossRefPubMed
6.
Bland KI, Klamer TW, Polk HC, Jr, Knutson CO. Isolated regional lymph node dissection: morbidity, mortality and economic considerations. Ann Surg. 1981;193:372–6.CrossRefPubMed
7.
Hudson CN, Shulver H, Lowe DC. The surgery of “inguino-femoral” lymph nodes: is it adequate or excessive? Int J Gynecol Cancer. 2004;14:841–5.CrossRefPubMed
8.
de Vries M, Vonkeman WG, van Ginkel RJ, Hoekstra HJ. Morbidity after inguinal sentinel lymph node biopsy and completion lymph node dissection in patients with cutaneous melanoma. Eur J Surg Oncol. 2006;32:785–9.CrossRefPubMed
9.
Tonouchi H, Ohmori Y, Kobayashi M, Konishi N, Tanaka K, Mohri Y, et al. Operative morbidity associated with groin dissections. Surg Today. 2004;34:413–8.CrossRefPubMed
10.
Abraham V, Ravi R, Shrivastava BR. Primary reconstruction to avoid wound breakdown following groin block dissection. Br J Plast Surg. 1992;45:211–3.CrossRefPubMed
11.
Chester DL, Waters R. Adverse alteration of wound flora with topical negative-pressure therapy: a case report. Br J Plast Surg. 2002;55:510–1.CrossRefPubMed
12.
Han LY, Schimp V, Oh JC, Ramirez PT. A gelatin matrix-thrombin tissue sealant (FloSeal) application in the management of groin breakdown after inguinal lymphadenectomy for vulvar cancer. Int J Gynecol Cancer. 2004;14:621–4.CrossRefPubMed
13.
Rouzier R, Haddad B, Dubernard G, Dubois P, Paniel BJ. Inguinofemoral dissection for carcinoma of the vulva: effect of modifications of extent and technique on morbidity and survival. J Am Coll Surg. 2003;196:442–50.CrossRefPubMed
14.
Ingvar C, Erichsen C, Jonsson PE. Morbidity following prophylactic and therapeutic lymph node dissection for melanoma—a comparison. Tumori. 1984;70:529–33.PubMed
15.
Baas PC, Schraffordt Koops H, Hoekstra HJ, van Bruggen JJ, van der Weele LT, Oldhoff J, et al. Groin dissection in the treatment of lower-extremity melanoma. Short-term and long-term morbidity. Arch Surg. 1992;127:281–6.PubMed
16.
Bevan-Thomas R, Slaton JW, Pettaway CA. Contemporary morbidity from lymphadenectomy for penile squamous cell carcinoma: the M.D. Anderson Cancer Center Experience. J Urol. 2002;167:1638–42.
17.
Serpell JW, Carne PW, Bailey M. Radical lymph node dissection for melanoma. ANZ J Surg. 2003;73:294–9.CrossRefPubMed
18.
Shaw JH, Rumball EM. Complications and local recurrence following lymphadenectomy. Br J Surg. 1990;77:760–4.CrossRefPubMed
19.
Bouchot O, Rigaud J, Maillet F, Hetet JF, Karam G. Morbidity of inguinal lymphadenectomy for invasive penile carcinoma. Eur Urol. 2004;45:761–5; discussion 765–6.CrossRefPubMed
20.
Sabel MS, Griffith KA, Arora A, Shargorodsky J, Blazer DG 3rd, Rees R, et al. Inguinal node dissection for melanoma in the era of sentinel lymph node biopsy. Surgery. 2007;141:728–35.CrossRefPubMed
21.
Coit DG, Peters M, Brennan MF. A prospective randomized trial of perioperative cefazolin treatment in axillary and groin dissection. Arch Surg. 1991;126:1366–71; discussion 1371–2.PubMed
22.
Mortenson MM, Xing Y, Weaver S, Lee JE, Gershenwald JE, Lucci A, et al. Fibrin sealant does not decrease seroma output or time to drain removal following inguino-femoral lymph node dissection in melanoma patients: a randomized controlled trial (NCT00506311). World J Surg Oncol. 2008;6:63.CrossRefPubMed
23.
NCI. Common Toxicity Criteria, Version 2.0. In Edition National Cancer Institute Cancer Therapy Evaluation Program 1998.
24.
Armer JM, Radina ME, Porock D, Culbertson SD. Predicting breast cancer-related lymphedema using self-reported symptoms. Nurs Res. 2003;52:370–9.CrossRefPubMed
25.
Armer JM, Whitman M. The problem of lymphedema following breast cancer treatment: prevalence, symptoms, and self-management. Lymphology. 2002;35:153–9.
26.
Gaarenstroom KN, Kenter GG, Trimbos JB, Agous I, Amant F, Peters AA, et al. Postoperative complications after vulvectomy and inguinofemoral lymphadenectomy using separate groin incisions. Int J Gynecol Cancer. 2003;13:522–7.CrossRefPubMed
27.
Balch CM, Buzaid AC, Soong SJ, Atkins MB, Cascinelli N, Coit DG, et al. Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol. 2001;19:3635–48.PubMed
28.
Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM. Prevalence of overweight and obesity in the United States, 1999–2004. JAMA. 2006;295:1549–55.CrossRefPubMed
29.
Wang Y, Beydoun MA, Liang L, Caballero B, Kumanyika SK. Will all Americans become overweight or obese? Estimating the progression and cost of the US obesity epidemic. Obesity (Silver Spring). 2008;16:2323–30.CrossRef
30.
Balch CM. The role of elective lymph node dissection in melanoma: rationale, results, and controversies. J Clin Oncol. 1988;6:163–72.PubMed
31.
NCCN. National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology—Melanoma, Version 2. In Edition National Comprehensive Cancer Network 2009.
32.
Guggenheim MM, Hug U, Jung FJ, Rousson V, Aust MC, Calcagni M, et al. Morbidity and recurrence after completion lymph node dissection following sentinel lymph node biopsy in cutaneous malignant melanoma. Ann Surg. 2008;247:687–93.CrossRefPubMed
33.
Karakousis CP. Surgical procedures and lymphedema of the upper and lower extremity. J Surg Oncol. 2006;93:87–91.CrossRefPubMed
34.
Smith G. Primary postoperative wound infection due to staphylococcus pyogenes. Curr Probl Surg. 1979;16:1–56.CrossRefPubMed
35.
Bozzetti F, Terno G, Camerini E, Baticci F, Scarpa D, Pupa A. Pathogenesis and predictability of central venous catheter sepsis. Surgery. 1982;91:383–9.PubMed
36.
Wilson JA, Clark JJ. Obesity: impediment to postsurgical wound healing. Adv Skin Wound Care. 2004;17:426–35.CrossRefPubMed
37.
38.
39.
40.
Spiess PE, Hernandez MS, Pettaway CA. Contemporary inguinal lymph node dissection: minimizing complications. World J Urol. 2009;27:205–12.CrossRefPubMed
41.
Karakousis CP, Heiser MA, Moore RH. Lymphedema after groin dissection. Am J Surg. 1983;145:205–8.CrossRefPubMed
42.
Badgwell B, Xing Y, Gershenwald JE, Lee JE, Mansfield PF, Ross MI, et al. Pelvic lymph node dissection is beneficial in subsets of patients with node-positive melanoma. Ann Surg Oncol. 2007;14:2867–75.CrossRefPubMed
43.
Gould N, Kamelle S, Tillmanns T, Scribner D, Gold M, Walker J, et al. Predictors of complications after inguinal lymphadenectomy. Gynecol Oncol. 2001;82:329–32.CrossRefPubMed
44.
Petrek JA, Senie RT, Peters M, Rosen PP. Lymphedema in a cohort of breast carcinoma survivors 20 years after diagnosis. Cancer. 2001;92:1368–77.CrossRefPubMed
45.
Herwaldt LA, Cullen JJ, Scholz D, French P, Zimmerman MB, Pfaller MA, et al. A prospective study of outcomes, healthcare resource utilization, and costs associated with postoperative nosocomial infections. Infect Control Hosp Epidemiol. 2006;27:1291–8.CrossRefPubMed
46.
Green JW, Wenzel RP. Postoperative wound infection: a controlled study of the increased duration of hospital stay and direct cost of hospitalization. Ann Surg. 1977;185:264–8.CrossRefPubMed
47.
Kirkland KB, Briggs JP, Trivette SL, Wilkinson WE, Sexton DJ. The impact of surgical-site infections in the 1990s: attributable mortality, excess length of hospitalization, and extra costs. Infect Control Hosp Epidemiol. 1999;20:725–30.CrossRefPubMed
48.
Reilly J, Twaddle S, McIntosh J, Kean L. An economic analysis of surgical wound infection. J Hosp Infect. 2001;49:245–9.CrossRefPubMed
49.
Gastmeier P. Postdischarge surveillance for surgical site infection: the continuing challenge. Infect Control Hosp Epidemiol. 2006;27:1287–90.CrossRefPubMed
50.
Zhang SH, Sood AK, Sorosky JI, Anderson B, Buller RE. Preservation of the saphenous vein during inguinal lymphadenectomy decreases morbidity in patients with carcinoma of the vulva. Cancer. 2000;89:1520–5.CrossRefPubMed
51.
Dardarian TS, Gray HJ, Morgan MA, Rubin SC, Randall TC. Saphenous vein sparing during inguinal lymphadenectomy to reduce morbidity in patients with vulvar carcinoma. Gynecol Oncol. 2006;101:140–2.CrossRefPubMed
52.
Zhang X, Sheng X, Niu J, Li H, Li D, Tang L, et al. Sparing of saphenous vein during inguinal lymphadenectomy for vulval malignancies. Gynecol Oncol. 2007;105:722–6.CrossRefPubMed
53.
Tobias-Machado M, Tavares A, Molina WR, Jr., Forseto PH Jr, Juliano RV, Wroclawski ER. Video endoscopic inguinal lymphadenectomy (VEIL): initial case report and comparison with open radical procedure. Arch Esp Urol. 2006;59:849–52.PubMed
54.
Tobias-Machado M, Tavares A, Ornellas AA, Molina WR Jr, Juliano RV, Wroclawski ER. Video endoscopic inguinal lymphadenectomy: a new minimally invasive procedure for radical management of inguinal nodes in patients with penile squamous cell carcinoma. J Urol. 2007;177:953–7; discussion 958.CrossRefPubMed
55.
Tobias-Machado M, Tavares A, Silva MN, Molina WR Jr, Forseto PH, Juliano RV, et al. Can video endoscopic inguinal lymphadenectomy achieve a lower morbidity than open lymph node dissection in penile cancer patients? J Endourol. 2008;22:1687–91.CrossRefPubMed
56.
Josephson DY, Jacobsohn KM, Link BA, Wilson TG. Robotic-assisted endoscopic inguinal lymphadenectomy. Urology. 2009;73:167–70; discussion 170–1.CrossRefPubMed
57.
Lin JY, DuBeshter B, Angel C, Dvoretsky PM. Morbidity and recurrence with modifications of radical vulvectomy and groin dissection. Gynecol Oncol. 1992;47:80–6.CrossRefPubMed
58.
Kulkarni JN, Kamat MR. Prophylactic bilateral groin node dissection versus prophylactic radiotherapy and surveillance in patients with N0 and N1-2A carcinoma of the penis. Eur Urol. 1994;26:123–8.PubMed
59.
Bell JG, Lea JS, Reid GC. Complete groin lymphadenectomy with preservation of the fascia lata in the treatment of vulvar carcinoma. Gynecol Oncol. 2000;77:314–8.CrossRefPubMed
Metadata
Title
Prospective Assessment of Postoperative Complications and Associated Costs Following Inguinal Lymph Node Dissection (ILND) in Melanoma Patients
Authors
Sharon B. Chang, MD
Robert L. Askew, MPH
Yan Xing, MD, PhD
Storm Weaver, BA
Jeffrey E. Gershenwald, MD
Jeffrey E. Lee, MD
Richard Royal, MD
Anthony Lucci, MD
Merrick I. Ross, MD
Janice N. Cormier, MD, MPH
Publication date
01-10-2010
Publisher
Springer-Verlag
Published in
Annals of Surgical Oncology / Issue 10/2010
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-010-1026-z

Other articles of this Issue 10/2010

Annals of Surgical Oncology 10/2010 Go to the issue

Bone and Soft Tissue Sarcomas

Role of Surgery Combined with Kinase Inhibition in the Management of Gastrointestinal Stromal Tumor (GIST)

Thoracic Oncology

Volume-Based Parameter of 18F-FDG PET/CT in Malignant Pleural Mesothelioma: Prediction of Therapeutic Response and Prognostic Implications

Melanomas

Utility of Preoperative 18F-FDG PET/CT and Brain MRI in Melanoma Patients with Palpable Lymph Node Metastases

Hepatobiliary Tumors

Factors Determining the Sensitivity of Intraoperative Ultrasonography in Detecting Colorectal Liver Metastases in the Modern Era

Breast Oncology

Axillary Recurrence in Breast Cancer Patients with Isolated Tumor Cells in the Sentinel Lymph Node [AJCC N0(i+)]

Head and Neck Oncology

Importance of Age as a Prognostic Factor for Tonsillar Carcinoma